Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
Bromfenacum
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
Bromfenac
Bromfenac sodium
Bromfenaco
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Brand Names
Pred-Gati-Brom
Xibrom
Bromsite 0.075%
Bromfenac
Bromday
Bromfenac Sodium
Pred-Brom
Apo-bromfenac
Bromfenac Ophthalmic Solution 0.09%
Yellox
Bromfenac Ophthalmic Solution, 0.09%
Auro-bromfenac
Bromfenac Ophthalmic Solution
Pred Phos-Gati-Brom
Pred Phos - Brom
Prolensa
Bromfenac 0.075%
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682